Beacon Financial Advisory »

Iovance Biotherapeutics shares owned by Beacon Financial Advisory

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Beacon Financial Advisory from 13F filings

Historical chart of Beacon Financial Advisory investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Beacon Financial Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Beacon Financial Advisory

Quarter filed Position value Share count Share price at filing
2024-12-31 $152k 21k 7.40
2024-09-30 $198k 21k 9.39
2024-06-30 $119k 15k 8.02

More positions owned by Beacon Financial Advisory

J P Morgan Exchange Traded F Equity Premium (JEPI)
Capital Group Dividend Value Shs Creation Uni (CGDV)
First Tr Value Line Divid In SHS (FVD)
J P Morgan Exchange Traded F Nasdaq Eqt Prem (JEPQ)
Apple (AAPL)
Pimco Etf Tr Multisector Bd (PYLD)
Vanguard Specialized Funds Div App Etf (VIG)
T Rowe Price Etf Cap Appreciation (TCAF)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
First Tr Exchng Traded Fd Vi Actv Fctr Smcp (AFSM)

View all positions for Beacon Financial Advisory

Top funds holding Iovance Biotherapeutics

Vanguard Group
MHR Fund Management
BlackRock
Perceptive Advisors
State Street Corporation
Hood River Capital Management
Soleus Capital Management
Geode Capital Management
T. Rowe Price Investment Management
Susquehanna International
Macquarie Group
Artisan Partners Limited Partnership
Long Focus Capital Management
Goldman Sachs Group
Morgan Stanley

View all funds holding Iovance Biotherapeutics